Genetic Characterization of Movement Disorders and Dementias
Part of paid clinical trials in Baltimore, Maryland.
- Sponsor
- National Institute on Aging (NIA)
- Study ID
- NCT02014246
- Status
- Recruiting
Conditions
- Dementia
- Movement Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 120 Years
- Healthy Volunteers
- Accepted
Study Details
Background: There are two basic types of movement disorders. Some cause excessive movement, some cause slowness or lack of movement. Some of these are caused by mutations in genes. On the other hand, dementia is a condition of declining mental abilities, especially memory. Dementia can occur at any age but becomes more frequent with age. Researchers want to study the genes of families with a history of movement disorders or dementia. They hope to find a genetic cause of these disorders. This can help them better understand and treat the diseases. This study will not be limited to a particular disorder, but will study all movement disorders or dementias in general. This study will perform genetic testing to identify the genetic causes of movement disorders and dementia. Today, genetic testing can be done to analyze multiple genes at the same time. This increases the chances of finding the genetic cause of movement disorders and dementias. Objectives: To learn more about movement disorders and dementia, their causes, and treatments. Eligibility: Adults and children with a movement disorder or dementia, and their family members. Healthy volunteers. Design: Participants will be screened with medical history and blood tests. Some will have physical exam. Participants will give a blood sample by a needle in the arm. This can be done at the clinic, by their own doctor, or at home. Alternatively, a saliva sample may be provided if a blood sample cannot be obtained. Participants can opt to send an extra blood sample to a repository for future study. Genetic test will be done on these samples. The samples will be coded. The key to the code will remain at NIA. Only NIA investigators will have access to the code key. Participants can request to receive results of the tests. Participation is generally a single visit. Participants may be called back for extra
Key Dates
- Start date
- Jul 14, 2003
- Status verified
- Sep 2025
- Primary completion
- Dec 31, 2059
- Completion
- Dec 31, 2059
Study Design
- Enrollment
- 12,000 participants (estimated)
Arms
- Arm: 1Participants with confirmed or suspected movement disorder or dementia diagnosis and their affected and unaffected family members will be potential candidates for the study, well as unrelated, healthy individuals (known as control samples.
- Arm: 2We plan to enroll 12,000 study subjects (10,000 patients, 1,000 asymptomatic family members, 1,000 neurological normal controls) for this study
Primary Outcome Measure
Finding genetic cause of disease [ Time Frame: Identification of pathogenic genetic variants ]
Central Contacts
- Bryan J Traynor, M.D.(301) 451-7606
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| National Institute of Aging, Clinical Research Unit | Baltimore | Maryland | 21224 |
Find similar trials in Baltimore, MD
Related Studies
- Human Movement DatabaseRecruiting · National Institutes of Health Clinical Center (CC) · Bethesda, Maryland
- Phenotype/Genotype Correlations in Movement DisordersRecruiting · National Institute of Neurological Disorders and Stroke (NINDS) · Bethesda, Maryland
- Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older AdultsPHASE4 · Recruiting · Duke University · Birmingham, Alabama
- PET Imaging of Cyclooxygenases in Neurodegenerative Brain DiseasePHASE1 · Recruiting · National Institute of Mental Health (NIMH) · Bethesda, Maryland